Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Interstitial pneumonitis following rituximab therapy for immune thrombocytopenic purpura (ITP).

Literature DB >> 15307117

Interstitial pneumonitis following rituximab therapy for immune thrombocytopenic purpura (ITP).

R Swords, D Power, M Fay, R O'Donnell, P T Murphy.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2004 PMID： 15307117 DOI： 10.1002/ajh.20135

Source DB: PubMed Journal: Am J Hematol ISSN： 0361-8609 Impact factor: 10.047

Keyword Cloud
Cited

× No keyword cloud information.

14 in total

Review 1. Pulmonary toxicities from targeted therapies: a review.

Authors: Nicholas A Barber; Apar Kishor Ganti
Journal: Target Oncol Date: 2011-11-11 Impact factor: 4.493

2. Fatal pulmonary fibrosis after rituximab administration.

Authors: Marie-Camille Chaumais; Arnaud Garnier; François Chalard; Michel Peuchmaur; Stephane Dauger; Evelyne Jacqz-Agrain; Georges Deschênes
Journal: Pediatr Nephrol Date: 2009-04-25 Impact factor: 3.714

3. Adverse events linked with the use of chimeric and humanized anti-CD20 antibodies in children with idiopathic nephrotic syndrome.

Authors: Alice Bonanni; Marta Calatroni; Matteo D'Alessandro; Sara Signa; Enrica Bertelli; Michela Cioni; Eddi Di Marco; Roberto Biassoni; Gianluca Caridi; Giulia Ingrasciotta; Roberta Bertelli; Armando Di Donato; Maurizio Bruschi; Alberto Canepa; Giorgio Piaggio; Pietro Ravani; Gian Marco Ghiggeri
Journal: Br J Clin Pharmacol Date: 2018-03-25 Impact factor: 4.335

4. Severe pulmonary adverse effects in lymphoma patients treated with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus rituximab.

Authors: Kyu-Hyoung Lim; Ho-Il Yoon; Young Ae Kang; Keun-Wook Lee; Jee Hyun Kim; Soo-Mee Bang; Jae Ho Lee; Choon-Taek Lee; Jong Seok Lee
Journal: Korean J Intern Med Date: 2010-02-26 Impact factor: 3.165

5. Increased incidence of interstitial pneumonia by CHOP combined with rituximab.

Authors: Daisuke Ennishi; Yasuhito Terui; Masahiro Yokoyama; Yuko Mishima; Shunji Takahashi; Kengo Takeuchi; Kazuma Ikeda; Mitsune Tanimoto; Kiyohiko Hatake
Journal: Int J Hematol Date: 2008-05 Impact factor: 2.490

6. Rituximab-induced hypersensitivity pneumonitis.

Authors: Adriano R Tonelli; Richard Lottenberg; Robert W Allan; P S Sriram
Journal: Respiration Date: 2008-10-09 Impact factor: 3.580

Review 7. Infiltrative lung diseases: complications of novel antineoplastic agents in patients with hematological malignancies.

Authors: Bobbak Vahid; Paul E Marik
Journal: Can Respir J Date: 2008 May-Jun Impact factor: 2.409